P0415: Bone turnover biomarkers alteration in patients with Inflammatory Bowel Disease.ECCO'25Year: 2025
Authors: Omran, S.(1)*;Gamal Eldeen, H.(1);Abdel Latif, Z.(1);Abdou, D.(2);Hamdy, R.(3);Gaber, A.(1);Ali, A.(1);Shehab, H.(1);El Raziky, M.(1);
(1)Faculty of Medicine- Kasr Alani- Cairo University, Gastroenterology- Hepatology and Tropical medicine, Giza, Egypt;(2)Faculty of Medicine- Kasr Alani- Cairo University, Chemical pathology, Giza, Egypt;(3)Faculty of Medicine- Kasr Alani- Cairo University, Rheumatology and Rehabilitation, Giza, Egypt;
P0416: Efficacy and safety of oral sulphate tablet for bowel preparation in patients with moderate to severe ulcerative colitis: a multicenter cohort studyECCO'25Year: 2025
Authors: Song, J.H.(1)*;Shin, J.(2);Kong, S.M.(3);Cha, B.(4);Hong, J.T.(4);Kwon, K.S.(4);
(1)Konkuk University Medical Center, Department of internal Medicine, Seoul, Korea- Republic Of;(2)Inha university hospital, Internal Medicine gastroenterology and hepatology, Incheon, Korea- Republic Of;(3)Sungkyunkwan University School of Medicine, 3Department of Medicine, Changwon, Korea- Republic Of;(4)Inha University Hospital, Department of Internal Medicine, Incheon, Korea- Republic Of;
Kim, Kyeong Ok, et al. "Efficacy, safety and tolerability of oral sulphate tablet for bowel preparation in patients with inflammatory bowel disease: A multicentre randomized controlled study." Journal of Crohn's and Colitis 16.11 (2022): 1706-1713.
Manes, Gianpiero, et al. "Appropriateness and diagnostic yield of colonoscopy in the management of patients with ulcerative colitis: a prospective study in an open access endoscopy service." Inflammatory bowel diseases 14.8 (2008): 1133-1138.
Yang, Hyo‐Joon, et al. "Novel sulfate tablet PBK‐1701TC versus oral sulfate solution for colon cleansing: A randomized phase 3 trial." Journal of Gastroenterology and Hepatology 35.1 (2020): 29-36.
Calderwood, Audrey H., et al. "Boston Bowel Preparation Scale scores provide a standardized definition of adequate for describing bowel cleanliness." Gastrointestinal endoscopy 80.2 (2014): 269-276.
P0417: Impact of Cytomegalovirus infection on patients with Inflammatory Bowel Disease in the Southern Area of Gran Canaria: a case-control study.ECCO'25Year: 2025
Authors: Peñate BolañosPhD, M.(1)*;Tosco-Nuñez, T.(2);Hernández Expósito, N.(1);Rodríguez Castellot, J.(1);Ciordia Nalda, I.(1);Alemán Gonzalez, H.(1);Quevedo Ruano, R.(3);Monescillo Francia, A.(1);
(1)Hospital Universitario Insular de Gran Canaria, Servicio de Aparato Digestivo, Las Palmas de Gran Canaria, Spain;(2)Hospital Universitario Insular de Gran Canaria, Servicio de Microbiología, Las Palmas de Gran Canaria, Spain;(3)Hospital Universitario Insular de Gran Canaria, Servicio Aparato Digestivo, Las Palmas de Gran Canaria, Spain;
1.Dutta S, Ray U. Cytomegalovirus (CMV) as a cause of exacerbation of ulcerative colitis (UC). An approach to diagnosis and management. Indian Journal of Medical Microbiology. noviembre de 2023;46:100469.
2. Kwon J, Fluxá D, Farraye FA, Kröner PT. Cytomegalovirus-related colitis in patients with inflammatory bowel disease. International Journal of Colorectal Disease. 1 de marzo de 2022;37(3):685-91.
3. Mourad FH, Hashash JG, Kariyawasam VC, Leong RW. Ulcerative Colitis and Cytomegalovirus Infection: From A to Z. Journal of Crohn’s and Colitis. 7 de septiembre de 2020;14(8):1162-71.
4. Hazır-Konya H, Avkan-Oğuz V, Akpınar H, Sağol Ö, Sayıner A. Investigation of Cytomegalovirus in Intestinal Tissue in a Country With High CMV Seroprevalence. Turk J Gastroenterol. 1 de febrero de 2021;32(2):123-32.
P0418: The implementation of IBD-dedicated multidisciplinary healthcare pathway improves patients’ satisfaction and reduces disability in patients with IBDECCO'25Year: 2025
Authors: Buisson, A.(1)*;Banana Hamadidi, A.(1);Dumas, V.(1);Dodel, M.(1);Coban, D.(1);Bazoge, M.(1);Rivière, C.(1);Heux, J.(1);Pereira, B.(1);
(1)CHU Clermont-Ferrand, IBD Unit, Clermont-Ferrand, France;
P0419: Impact of psychopathology and gut-microbiota on disease progression in Ulcerative Colitis: a five-year follow-up studyECCO'25Year: 2025
Authors: D'Onofrio, A.M.(1);Chiera, E.(2)*;Gomez-Nguyen, A.(3);Di Vincenzo, F.(4);Spagnolo, G.(5);Ferrarese, D.(5);Cammarota, G.(4);Camardese, G.(1);Scaldaferri, F.(4);
(1)Fondazione Policlinico Universitario "A. Gemelli" IRCCS- Università Cattolica del Sacro Cuore, Department of Neuroscience- Psychiatry Unit, Roma, Italy;(2)Università Cattolica del Sacro Cuore, Department of Translational Medicine and Surgery, Roma, Italy;(3)Digestive Health Research Institute- Case Western Reserve University, Department of Medicine, Cleveland, United States;(4)Fondazione Policlinico Universitario "A. Gemelli" IRCCS- Università Cattolica del Sacro Cuore, CEMAD Digestive Disease Center, Roma, Italy;(5)Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Clinical Psychology Unit, Roma, Italy;
P0420: Interim analysis of real-world-data on PROs and biomarker remission collected through the Health Outcome Observatory (H2O) consortium in IBD patientsECCO'25Year: 2025
Authors: Novacek, G.(1)*;Fierens, L.(2);Primas, C.(1);Ferrante, M.(2);Schreiner, P.(1);Borruel, N.(3);Serra, X.(3);Dabsch, S.(1);Schilling, V.(1);Frick, A.(1);Reinisch, W.(1);Schweiger, K.(1);Galan, G.(4);Ferri, M.(4);Ritschl, V.(5);Mosor, E.(5);Long, P.(5);Winkler, E.(1);Mooslechner, T.(1);Wisniowski, K.(1);Kazemi-Shirazi, L.(1);Bäuerle, M.(1);Dejaco, C.(1);Stamm, T.(5);
(1)Medical University of Vienna, Department of Internal Medicine III, Vienna, Austria;(2)Catholic University Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(3)Hospital Universitari Vall d'Hebron, Crohn's and Colitis Attention Unit, Barcelona, Spain;(4)Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institut de Recerca VHIR, Barcelona, Spain;(5)Medical University of Vienna, Institute for Outcome Research, Vienna, Austria;
1Fierens L, Carney N, Novacek G, van der Woude CJ, Siegmund B, Casellas F, Borruel N, Huberts AS, Sonnenberg E, Gerold N, Primas C, Hedin CRH, Stamm T, Julsgaard M, Fiorino G, Radice S, Zini MLL, Gross E, Sander C, Arijs I, Vakouftsi VR, Koltai T, Health Outcomes Observatory H O Patient Advisory Board For Inflammatory Bowel Diseases, Health Outcomes Observatory H2O Steering Committee, Charlafti I, Ferrante M. A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process. J Crohns Colitis. 2024 Oct 15;18(10):1583-1595. doi: 10.1093/ecco-jcc/jjad195. PMID: 38019894.
P0421: Clinical validity of a seroproteomic index of endoscopic activity in pediatric Crohn's diseaseECCO'25Year: 2025
Authors: Orlanski Meyer , E.(1);Dotson , J.(2);Saeed , S.(3);Zitomersky , N.(4);Focht , G.(1)*;Rabizadeh , S.(5);Sockolow , R.(6);Griffiths , A.(7);Navas-López , V.M.(8);Sladek , M.(9);Baldassano , R.(10);Otley , A.(11);Spencer , E.(12);Ho , J.(13);Dervieux , T.(13);Turner , D.(1);Dubinsky , M.(12);
(1)Shaare Zedek Medical Center, Gastroenterology, Jerusalem, Israel;(2)University of Arkansas for Mediical Sciences, Gastrorenterology, Little Rock, United States;(3)Wright State University Boonshoft School of Medicine, Gastroenterology, Dayton, United States;(4)Boston Children’s Hospital, Gastroenterology, Boston, United States;(5)Cedars Sinai Medical Center, Gastroenterology, Los Angeles, United States;(6)Weill Cornell University, Gastroenterology, New York, United States;(7)Hospital for Sick Children, Gastroenterology, Toronto, Canada;(8)University Hospital of Málaga, Gastroenterology, Malaga, Spain;(9)kademickie Centrum Komputerowe Cyfronet AGH, Gastroenterology, Krakow, Poland;(10)The Children's Hospital of Philadelphia, Gastroenterology, Philadelphia, United States;(11)IWK health, Gastroenterology, Halifx, Canada;(12)Mount Sinai Kravis Children’s Hospital, Gastroenterology, New York, United States;(13)Prometheus Laboratories, Research and Development, San Diego, United States;
P0422: CROHN-PREP study: Simplified bowel preparation adapted to small bowel capsule endoscopy in patients with Crohn’s disease; comparison with the reference method.ECCO'25Year: 2025
Authors: Rouveyre, R.(1)*;Collins, M.(1);De Maissin, A.(2);Flamant, M.(1,3);Trang, C.(1,4);Bouguen, G.(5);Dib, N.(6);Bourreille, A.(1);Le Berre, C.(1);
(1)Institut des Maladies de l'Appareil Digestif - Nantes University Hospital, Loire Atlantique 44, Nantes, France;(2)CHD Vendée, Vendée 85, La Roche-sur-Yon, France;(3)Jules Verne clinic, Loire Atlantique 44, Nantes, France;(4)Confluent Clinic, Loire Atlantique 44, Nantes, France;(5)Rennes University Hospital, Ille-et-Vilaine 35, Rennes, France;(6)Angers University Hospital, Maine et Loire 49, Angers, France;
P0423: Anastomotic leakage after ileoanal pouch surgery: risk factors and salvageECCO'25Year: 2025
Authors: Moojen, T.(1)*;Vlug, M.(1);Visser, E.(1);Reijntjes, M.(1);Lange, J.(2);Bislenghi, G.(3);Carvello, M.(4);Warusavitarne, J.(5);Hompes, R.(1);Stassen, L.(6);Faiz, O.(5);Spinelli, A.(4);D'Hoore, A.(3);Bemelman, W.(1);
(1)Amsterdam UMC, Department of Surgery, Amsterdam, The Netherlands;(2)UMC Groningen, Department of Abdominal Surgery, Groningen, The Netherlands;(3)UZ Leuven, Department of Abdominal Surgery, Leuven, Belgium;(4)Humanitas Research Hospital, Division of Colon and Rectal Surgery, Milan, Italy;(5)St Mark's Hospital, Department of Colorectal Surgery, London, United Kingdom;(6)Maastricht UMC, Department of Surgery, Maastricht, The Netherlands;
P0424: Utility of superb microvascular imaging for predicting terminal ileal lesion activity in Crohn’s diseaseECCO'25Year: 2025
Authors: Nasuno, M.(1)*;Shimoyama, K.(1);Hamada, T.(1);Shimazaki, H.(1);Sugiyama, K.(1,2);Miyakawa, M.(1);Tanaka, H.(1);
(1)Sapporo IBD Clinic, Department of Inflammatory Bowel Disease, Sapporo, Japan;(2)Sapporo Central Hospital, Department of Gastroenterology, Sapporo, Japan;
1) Nasuno M, Shimazaki H, Nojima M, Hamada T, Sugiyama K, Miyakawa M, Tanaka H. Serum leucine-rich alpha-2 glycoprotein levels for predicting active ultrasonographic findings in intestinal lesions of patients with Crohn’s disease in clinical remission. Medicine (Baltimore). 2023;102(32):e34628. doi: 10.1097/MD.0000000000034628.
P0425: Factors Associated with Biopsy-Proven Cuffitis in Ulcerative Colitis Patients Following Colectomy with Ileal Anal-Pouch AnastomosisECCO'25Year: 2025
Authors: Fishman, M.(1);Codish, M.(2);Rabinowitz, K.(1);Avni-Biron, I.(1);Godny, L.(1);Yanai, H.(1);Dotan, I.(1);Ollech, J.(3)*;
(1)Rabin Medical Center, Gastroenterology, Petah Tikva, Israel;(2)Tel-Aviv University, Faculty of Medicine, Tel aviv, Israel;(3)Rabin Medical Center, Gastroenterology, Petach Tikva, Israel;
P0426: Lumeneye digital proctoscopy is safe, and streamlines management of immune checkpoint inhibitor-induced colitisECCO'25Year: 2025
Authors: Ibraheim, H.(1,2)*;Alexander, J.L.(1);Balcorta, M.(2);Dolina, G.(2);Harrison, Z.(2);Young, K.(2);Powell, N.(1,2);
(1)Imperial College London, Department of Metabolism- Digestion and Reproduction, London, United Kingdom;(2)The Royal Marsden Hospital, Renal/melanoma unit, London, United Kingdom;
P0427: Nutritional factors associated with the presence of non-alcoholic fatty liver disease (NAFLD) in patients with inflammatory bowel disease (IBD)ECCO'25Year: 2025
Authors: Castelhano , N.S.(1);Oliveira , E.C.S.D.(1);Lopes , M.A.(1);Beraldo , R.F.(1);Baima , J.P.(1);Herrerias , G.S.P.(1);Quaglio , A.E.V.(2);Di Stasi , L.C.(3);Barbosa , W.F.(1);Silva , G.F.(1);Sassaki , L.Y.(1)*;
(1)São Paulo State University Unesp- Medical School, Department of Internal Medicine, Botucatu, Brazil;(2)Verum Ingredients, Botucatu Technology Park, Botucatu, Brazil;(3)São Paulo State University Unesp-Institute of Biosciences, Department of Biophysics and Pharmacology, Botucatu, Brazil;
P0428: Validation of the Urgency-Numeric Rating Scale in Ulcerative Colitis and correlation with endoscopic, histological and manometric activityECCO'25Year: 2025
Authors: Guimaraes, A.(1)*;Leal, T.(1);Caetano, A.C.(1);Barbosa, I.(2);Costa, D.(1);Carvalho, T.(1);Mendes, S.(1);Soares, J.(1);Rodrigues, Â.(1);Gonçalves, R.(1);
(1)Unidade Local de Saúde de Braga, Gastrenterology, Braga, Portugal;(2)Escola de Medicina Universidade do Minho, Gastrenterology, Braga, Portugal;
P0429: Endocytoscopy in real-time assessment of histological and endoscopic activity in ulcerative colitisECCO'25Year: 2025
Authors: Chaemsupaphan, T.(1,2)*;Ali, M.S.(1);Paramsothy, S.(1,3);Leong, R.W.(1,3);
(1)Concord Repatriation General Hospital, Gastroenterology and Liver Services, Sydney, Australia;(2)Siriraj Hospital Mahidol University, Gastroenterology, Bangkok, Thailand;(3)University of Sydney, Faculty of Medicine and Health, Sydney, Australia;
P0430: Central reading of ulcerative colitis endoscopic disease activity: Automated but with a human in the loop (2M+1H)ECCO'25Year: 2025
Authors: Battioui, C.(1);Gottlieb, K.(1)*;Wang, Y.(2);Brodskiy, P.(3);Haft-Javaherian, M.(3);Colucci, D.(2);Thomason, D.(2);Baxi, S.(2);
(1)Eli Lilly & Company, Clinical Research, Indianapolis, United States;(2)Iterative Health- Inc., Data & Insights, Cambridge, United States;(3)Iterative Health- Inc., Machine Learning, Cambridge, United States;
Food and Drug Administration. Ulcerative Colitis: Developing Drugs for Treatment [Internet]. 2022 [cited 2024 Oct 17]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/ulcerative-colitis-developing-drugs-treatment
Gottlieb, K., Daperno, M., Usiskin, K., Sands, B. E., Ahmad, H., Howden, C. W., . . . & Reinisch, W. (2021). Endoscopy and central reading in inflammatory bowel disease clinical trials: Achievements, challenges and future developments. Gut, 70(2), 418-426.
Rimondi, A., Gottlieb, K., Despott, E. J., Iacucci, M., Murino, A., & Tontini, G. E. (2023). Can artificial intelligence replace endoscopists when assessing mucosal healing in ulcerative colitis? A systematic review and diagnostic test accuracy meta-analysis. Digestive and Liver Disease, 56(7):1164-1172.
Cohen, I. G., Babic, B., Gerke, S., Xia, Q., Evgeniou, T., & Wertenbroch, K. (2023). How AI can learn from the law: Putting humans in the loop only on appeal. npj Digital Medicine, 6(1), 160.
P0431: Multiparametric Assessment of IBD, SpA and IBD-SpA patients to explore disease biomarkers and response predictorsECCO'25Year: 2025
Authors: Parisio, L.(1)*;Privitera, G.(2);Varca, S.(3);Perniola, S.(4);Alivernini, S.(4);Tolusso, B.(4);Petito, V.(5);Masi, L.(5);Napolitano, D.(1);Schiavoni, E.(1);Turchini, L.(1);Amatucci, V.(1);Scaldaferri, F.(6);Gasbarrini, A.(7);Armuzzi, A.(8);Gremese, E.(9);Guidi, L.(1);Pugliese, D.(10);
(1)Fondazione Policlinico A.Gemelli IRCCS, IBD Unit- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche, Rome, Italy;(2)Università degli studi di Milano, Internal Medicine, Milano, Italy;(3)Fondazione Policlinico A.Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy;(4)Fondazione Policlinico A.Gemelli IRCCS, Immunology Research Core Facility Gemelli Science and Technology Park GSTeP, Rome, Italy;(5)Fondazione Policlinico A.Gemelli IRCCS, CeMAD Translational Research Laboratories- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche, Rome, Italy;(6)Fondazione Policlinico A.Gemelli IRCCS, IBD Unit- CeMAD Translational Research Laboratories- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche- Dipartimento di Medicina e Chirurgia Traslazionale- Università Cattolica del Sacro Cuore, Rome, Italy;(7)Fondazione Policlinico A.Gemelli IRCCS, UOC Medicina Interna e Gastroenterologica- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche- Dipartimento di Medicina e Chirurgia Traslazionale- Università Cattolica del Sacro Cuore, Rome, Italy;(8)Humanitas Clinical and Research Center IRCCS, Gastroenterology, Milan, Italy;(9)Humanitas Clinical and Research Center IRCCS, Reumatology, Milan, Italy;(10)Fondazione Policlinico A.Gemelli IRCCS, UOS Gastroenterologia Ospedale Isola Tiberina Gemelli Isola- IBD Unit- Digestive Disease Center CeMAD- Dipartimento di Scienze Mediche e Chirurgiche- Dipartimento di Medicina e Chirurgia Traslazionale- Università Cattolica del Sacro Cuore, Rome, Italy;
P0432: CMV infection in IBD patients with disease flare in the era of advanced therapies and outpatient settingECCO'25Year: 2025
Authors: Pipek, B.(1)*;Zelinková, Z.(2);
(1)University Hospital and Faculty of Medicine and Dentistry Palacky University Olomouc, Department of Internal Medicine II-gastroenterology and geriatrics, Ostrava, Czech Republic;(2)Penta Hospitals Bory Bratislava, Department of gastroenterology, Bratislava, Slovakia;
Maresca, R et al. Cytomegalovirus Infection: An Underrated Target in Inflammatory Bowel Disease Treatment. J. Clin. Med. 2024, 13, 136
P0433: Pouchitis described by the SES-CD score is more associated with the need for biologics initiation after IPAA than endoscopic subscore of PDAIECCO'25Year: 2025
Authors: Simonič, J.(1)*;Simonič, P.(1);Bislenghi, G.(2);D’Hoore, A.(2);Verstockt, B.(1,3);Ferrante, M.(1,3);Vermeire, S.(1,3);Sabino, J.(1,3);
(1)KU Leuven, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(2)University Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium;(3)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;
References
(1) Jairath V, Feagan BG, Silverberg MS, et al. Mucosal healing with vedolizumab in patients with chronic pouchitis: EARNEST, a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. Published online 2024. doi: 10.1016/j.cgh.2024.06.037
(2) Sedano R, Nguyen TM, Almradi A, et al. Disease activity indices for pouchitis: A systematic review. Inflamm Bowel Dis. 2022;28(4):622-638. doi:10.1093/ibd/izab124
(3) Barnes EL, Long MD, Raffals L, et al. Development of the endoscopic pouch score for assessment of inflammatory conditions of the pouch. Clin Gastroenterol Hepatol. 2023;21(6):1663-1666.e3. doi: 10.1016/j.cgh.2022.04.026
P0434: Clinical patterns and prognosis according to the time of diagnosis in Korean IBD Patients with over 10 years of disease durationECCO'25Year: 2025
Authors: Park, Y.E.(1);Park, S.B.(2)*;Kang, S.B.(3);Park, Y.(4);Kim, D.(5);Na, S.Y.(6);Moon, W.(7);
(1)Inje University School of Medicine- Haeundae Paik Hospital, Division of Gastroenterology- Department of Internal Medicine, Busan, Korea- Republic Of;(2)Pusan National University School of Medicine and Research Institute for Convergence of Biomedical Science and Technology- Pusan National University Yangsan Hospital- Yangsan, Department of Internal Medicine, Busan, Korea- Republic Of;(3)Daejeon St. Mary's Hospital- College of Medicine- the Catholic University of Korea, Division of Gastroenterology- Department of Internal Medicine, Daejeon, Korea- Republic Of;(4)Ewha Womans University Seoul Hospital, Department of Internal Medicine, Seoul, Korea- Republic Of;(5)Konyang University College of Medicine, Department of Internal Medicine, Daejeon, Korea- Republic Of;(6)Incheon St. Mary’s Hospital- College of Medicine- The Catholic University of Korea, Division of Gastroenterology- Department of Internal Medicine, Incheon, Korea- Republic Of;(7)Kosin University School of Medicine, Department of Internal Medicine, Busan, Korea- Republic Of; IBD Research Group of the Korean Association for the Study of Intestinal Diseases (KASID)
1. Thia KT, Loftus EV, Jr., Sandborn WJ, Yang SK (2008) An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 103(12):3167-3182.2. Duricova D, Burisch J, Jess T, et al. Age-related differences in presentation and course of pediatric inflammatory bowel disease; an update on the populationbased literature. J Crohns Colitis 2014;8(11):1351–61. 5.3. Carroll MW, Kuenzig ME, Mack DR, et al. The impact of inflammatory bowel disease in Canada 2018: children and adolescents with IBD. J Can Assoc Gastroenterol 2019;2:S49–S67.
